Atlas Trials

Dose Individualization of Pemetrexed - IMPROVE-I

Clinical trial NCT03656549 · COMPLETED

Trial details

NCT number
NCT03656549
Sponsor
Radboud University Medical Center
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Non Small Cell Lung CancerMesothelioma
Start date
2019-02-01
Primary completion
2023-12-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.